Quality of life in COVID survivors and post COVID manifestations in a tertiary care hospital, Nalanda, Bihar


  • Shreya Shekhar Department of Pharmacology, BMIMS, Pawapuri, Nalanda, Bihar, India
  • Aman Kishor Department of Pharmacology, BMIMS, Pawapuri, Nalanda, Bihar, India
  • Zaki Anwar Zaman Department of Pharmacology, BMIMS, Pawapuri, Nalanda, Bihar, India




COVID-19, Post COVID manifestation, Dyspnoea, Anxiety, Rehabilitation


Background: COVID-19 pandemic had affected majority of the population across the world. Majority of the cases still complaining of post COVID symptoms. This study was undertaken to study the various pattern of post COVID-19 manifestations in this region in a group of patients attending hospital.

Methods: An observational study was undertaken in a group of 120 patients attending a tertiary care hospital. The patients were subjected for a detailed history and thorough physical examination and the details were entered in to a proforma. The data thus obtained was compiled and analysed.

Results: This study had shown than majority of cases were aged more than 50 years and most of them were females. The common post COVID-19 manifestations included joint pain, continued loss of taste and smell, dyspnoea, Anxiety/ depression and sleep disturbances in this study.

Conclusions: This study had observed continued symptoms from the episode of disease varying from mild to severe manifestations. This study urges for a comprehensive rehabilitation program for all COVID-19 patients.


Pneumonia in Wuhan, China. Available at: https://www.WHO.int/blueprint/10-01-2020-nfr-gcm.pdf?ua. Accessed on 22 December 2021.

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutie ́rrez-Ocampo E, Villamizar-Pen ̃a R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromesand immunosuppression. Lancet. 2020;395(10229):1033-4.

Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-44.

Mahmud R, Rahman M, Rassel MA, Monayem FB, Sayeed SKJ, Islam MS, Islam MM. Post COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary case center of Bangladesh. PLoS ONE. 2005;16(4):e0249644.

Moldofsky H, Patcai JJ. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. J Intern Med. 2011;11(1):37.

Leow MK. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). J Intern Med. 2005;63(2):197-202.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-8.

Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:3026.

Carfì A, Bernabei R, Landi F, Gemelli A. Against COVID-19 post-acute care study group persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5.




How to Cite

Shekhar, S., Kishor, A., & Zaman, Z. A. (2023). Quality of life in COVID survivors and post COVID manifestations in a tertiary care hospital, Nalanda, Bihar. International Journal of Basic & Clinical Pharmacology, 12(2), 199–201. https://doi.org/10.18203/2319-2003.ijbcp20230386



Original Research Articles